Incyte

IRS: 943136539
INCY
Incyte

Incyte focuses on the discovery and development of small-molecule drugs.

Founded
1991 (29 years)
CEO
Hervé Hoppenot
Investor RelationsSEC
Revenue
2 billion (2019)

Want to see more? Sign up!